⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7971304 | 0.84 | — | — | |
| SCHEMBL1941477 | 0.83 | FTO (0.45) | — | |
| SCHEMBL3980901 | 0.72 | — | — | |
| SCHEMBL14660760 | 0.69 | FTO (0.36) | — | |
| SCHEMBL7959704 | 0.65 | FTO (0.38) | — | |
| SCHEMBL30218785 | 0.65 | MAPT (0.64) | — | |
| SCHEMBL408340 | 0.65 | MAPT (0.64) | — | |
| SCHEMBL29367262 | 0.65 | MAPT (0.64) | — | |
| SCHEMBL1644389 | 0.64 | HPGD (0.41) | — | |
| SCHEMBL7969779 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11998615-B2 | Functionalized nanoparticles and their use in treating bacterial infections | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-06-04 | — | — | US | disclosed |
| US-20200271640-A1 | METHOD FOR SCREENING COMPOUNDS THAT MODULATE THE ACTIVITY OF THE ELECTRON TRANSPORT CHAIN | IMG PHARMA BIOTECH, S.L. (ES) | 2020-08-27 | — | — | US | disclosed |
| WO-2019053137-A1 | METHOD FOR SCREENING COMPOUNDS THAT MODULATE THE ACTIVITY OF THE ELECTRON TRANSPORT CHAIN | IMG PHARMA BIOTECH, S.L. (ES) | 2019-03-21 | — | — | WO | disclosed |
| EP-3457132-A1 | METHOD FOR SCREENING COMPOUNDS THAT MODULATE THE ACTIVITY OF THE ELECTRON TRANSPORT CHAIN | IMG Pharma Biotech, S.L. (ES) | 2019-03-20 | — | — | EP | disclosed |
| US-20090239243-A1 | Method of identifying compounds useful to treat neuronal degenerative diseases | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2009-09-24 | — | — | US | disclosed |
| US-20080206792-A1 | Method of identifying compounds useful to treat neuronal degenerative diseases | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2008-08-28 | — | — | US | disclosed |
| US-7358052-B2 | Catalytic amplification of multiplexed assay signals | MONOGRAM BIOSCIENCES, INC. (US) | 2008-04-15 | — | — | US | disclosed |
| US-20070265350-A1 | METHOD OF IDENTIFYING COMPOUNDS USEFUL TO TREAT NEURONAL DEGENERATIVE DISEASES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2007-11-15 | — | — | US | disclosed |
| US-20020197649-A1 | Catalytic amplification of multiplexed assay signals | MONOGRAM BIOSCIENCES, INC. | 2002-12-26 | — | — | US | disclosed |
| WO-2002097112-A2 | CATALYTIC AMPLIFICATION OF MULTIPLEXED ASSAY SIGNALS | ACLARA BIOSCIENCES, INC. (US) | 2002-12-05 | — | — | WO | disclosed |
| US-6229055-B1 | SYNTHESIS OF FLUORINATED RESORCINOL WHICH IS USEFUL IN THE PREPARATION OF FLUORINATED FLUORESCEIN AND RHODOL DYES SUITABLE FOR USE AS TRACERS, LABELS, OR INTERMEDIATES | MOLECULAR PROBES, INC. | 2001-05-08 | — | — | US | disclosed |
| US-6162931-A | Fluorinated xanthene derivatives | MOLECULAR PROBES, INC. (US) | 2000-12-19 | — | — | US | disclosed |